证券代码：600378 证券简称：昊华科技 公告编号：临 2024-075 昊华化工科技集团股份有限公司 2024 年前三季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 昊华化工科技集团股份有限公司（以下简称"公司"）根据《上海 证券交易所上市公司自律监管指引第 3 号——行业信息披露》及附件 《第十三号——化工》要求，现将公司 2024 年前三季度主要经营数 据披露如下： 说明：氟化锂受锂电市场需求不足影响，价格大幅下滑；烟片胶受东南亚停割期 和台风影响，采购价格增幅较大。 主要产品 2024 年 1-9 月平均 售价（元/吨） 2023 年 1-9 月平均 售价（元/吨） 变动比率（%） 氟碳化学品 29,896.48 25,583.71 16.86% 含氟锂电材料 24,216.20 37,043.58 -34.63 含氟聚合物 39,669.81 45,297.80 -12.42 含氟精细化学品 45,568.93 56,266.19 -19.01 含氟气体 94,400.30 107,781.6 ...

证券代码：600378 证券简称：昊华科技 公告编号：临 2024－074 昊华化工科技集团股份有限公司 第八届董事会第二十一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 昊华化工科技集团股份有限公司（以下简称"公司"或"昊华科 技"）第八届董事会第二十一次会议于 2024 年 10 月 29 日以通讯表 决的方式召开。会议通知等材料已于 2024 年 10 月 21 日以电子邮件 并短信通知的方式发送给公司董事、监事、高级管理人员。会议应出 席董事 9 名，实际出席董事 9 名，共收回有效表决票 9 份。会议的召 开符合相关法律、行政法规、部门规章、规范性文件和《公司章程》 的规定。 会议审议并通过如下议案： 一、关于审议《公司 2024 年第三季度报告》的议案 董事会同意《公司 2024 年第三季度报告》。 公司董事会审计委员会已审议通过相关议案。 表决结果：9 票同意，0 票反对，0 票弃权。 《昊华科技 2024 年第三季度报告》详见 2024 年 10 月 31 日上海 证券交易所网站（www.ss ...

证券代码：600378 证券简称：昊华科技 公告编号：临 2024-076 关于召开 2024 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 昊华化工科技集团股份有限公司 重要内容提示： 投资者可于 2024 年 11 月 8 日（星期五）至 11 月 14 日（星期 四）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或 通过公司邮箱 hhkj@sinochem.com 进行提问。公司将在说明会上 对投资者普遍关注的问题进行回答。 昊华化工科技集团股份有限公司（以下简称"公司"）已于 2024 年 10 月 31 日发布《昊华科技 2024 年第三季度报告》。为便于广大投资 者更全面、更深入地了解公司 2024 年第三季度经营成果、财务状况， 公司计划于 2024 年 11 月 15 日（星期五）上午 10:00-11:00 举行 2024 年第三季度业绩说明会，就投资者关心的问题进行交流。 一、说明会类型 本次业绩说明会以网络互动形式召开，公司将针对 2024 年第三 会议召开时间 ...

Financial Performance - The company's operating revenue for Q3 2024 was approximately CNY 3.67 billion, a decrease of 2.02% compared to the same period last year[4]. - Net profit attributable to shareholders for Q3 2024 was approximately CNY 315.18 million, an increase of 53.40% year-on-year[4]. - The basic earnings per share for Q3 2024 was CNY 0.2862, reflecting a 53.38% increase compared to the previous year[4]. - The net profit attributable to shareholders for the year-to-date period decreased by 18.60% compared to the same period last year, totaling approximately CNY 851.14 million[4]. - Total operating revenue for the first three quarters of 2024 was CNY 10,207,054,524.59, a decrease of 11.6% compared to CNY 11,548,377,736.51 in the same period of 2023[23]. - Net profit for the first three quarters of 2024 was CNY 890,814,058.88, a decline of 14.7% from CNY 1,044,765,679.89 in the same period of 2023[25]. - Earnings per share for the first three quarters of 2024 were CNY 0.7705, down from CNY 0.9451 in 2023, indicating a decrease of 18.5%[26]. - The company reported a net profit of 368 million CNY in the first three quarters of 2024, representing a year-on-year growth of 61.68%, with a comprehensive gross margin increase of 4.18 percentage points[16]. - In Q3 2024, the company achieved a net profit of 176 million CNY, a quarter-on-quarter increase of 13.98%[16]. Asset and Liability Management - Total assets at the end of the reporting period were approximately CNY 25.39 billion, an increase of 2.80% from the previous year[5]. - The company's total equity reached CNY 12,900,488,746.90 by the end of Q3 2024, compared to CNY 12,227,879,061.00 in the previous year, marking an increase of 5.5%[22]. - Total liabilities as of the end of Q3 2024 amounted to CNY 13,195,009,586.21, slightly up from CNY 13,157,697,326.70 at the end of Q3 2023[22]. - Non-current liabilities increased to CNY 3,682,697,874.68 in Q3 2024 from CNY 3,242,007,888.76 in Q3 2023, representing a growth of 13.6%[22]. Cash Flow Analysis - The net cash flow from operating activities for the year-to-date period decreased by 54.84% to approximately CNY 382.69 million[4]. - In the first three quarters of 2024, the company generated cash inflows from operating activities totaling ¥9,887,600,984.75, a decrease of approximately 9.9% compared to ¥10,977,413,826.57 in the same period of 2023[27]. - The net cash flow from operating activities for the first three quarters of 2024 was ¥382,687,596.59, down 54.9% from ¥847,479,094.95 in the previous year[28]. - The company reported cash outflows from investing activities of ¥1,550,737,093.62, an increase from ¥1,342,130,227.10 in the same period of 2023[28]. - The net cash flow from investing activities was -¥1,442,881,798.08, compared to -¥316,260,606.06 in the previous year, indicating a significant increase in cash outflow[28]. - Cash inflows from financing activities amounted to ¥7,465,222,208.81, up from ¥4,322,745,573.82 in the same period of 2023[28]. - The company's cash and cash equivalents at the end of the period were ¥1,733,630,163.24, down from ¥2,630,580,114.23 at the end of the same period in 2023[29]. - The company experienced a negative net increase in cash and cash equivalents of -¥1,071,456,294.67 for the first three quarters of 2024, compared to -¥298,954,472.90 in the previous year[29]. Acquisitions and Business Development - The company completed the acquisition of 100% equity in Sinochem Blue Sky Group, which has been consolidated into the company's financial statements since July 2024[6]. - The company completed the acquisition of 100% equity in Zhonghua Lantian, enhancing overall profitability and optimizing business structure[12]. - For the first nine months of 2024, the company achieved a revenue of 10.207 billion RMB, with Zhonghua Lantian contributing 4.946 billion RMB, representing a 93.96% increase compared to before the acquisition[14]. - The net profit attributable to shareholders for the first nine months was 851 million RMB, with Zhonghua Lantian contributing 328 million RMB, marking a 62.82% increase compared to before the acquisition[14]. - In Q3 2024, the company reported a revenue of 3.670 billion RMB, with Zhonghua Lantian contributing 1.814 billion RMB, reflecting a 95.32% increase compared to before the acquisition[14]. - The net profit attributable to shareholders in Q3 reached 315 million RMB, with Zhonghua Lantian contributing 163 million RMB, showing a 105.31% increase compared to before the acquisition[14]. Operational Efficiency and Market Outlook - The comprehensive gross profit margin improved significantly due to the successful implementation of cost reduction and efficiency enhancement measures[9]. - The company's overall gross margin improved by 1.06 percentage points year-on-year in Q3 2024, with a net profit growth of 53.40% year-on-year[15]. - The company reported a 2.02% slight decline in revenue year-on-year for Q3, but the integration of Zhonghua Lantian led to significant improvements in profitability[15]. - The company remains confident in the macroeconomic environment, aiming to leverage internal efficiency and external market potential for high-quality development[13]. - The company plans to accelerate major project construction and enhance internal efficiency to achieve annual operational goals[19]. Shareholder Information - The company has a total of 14,240 common shareholders at the end of the reporting period, with the largest shareholder holding 53.23% of the shares[11]. - The company’s major shareholders include state-owned enterprises, with significant shareholdings and some shares under judicial freeze[11]. Research and Development - The company applied for a total of 228 patents in the first nine months of 2024, including 172 invention patents[18].

证券代码：600378 证券简称：昊华科技 昊华化工科技集团股份有限公司 机构投资者调研记录 （2024 年 9 月 1 日-2024 年 10 月 21 日） 1. 调研时间：2024 年 9 月 1 日-2024 年 10 月 21 日 2. 调研地点：北京及线上 3. 调研形式：现场调研、线上交流 | --- | |----------------------------------------------------------| | | | 4. 机构名称 ：华夏基金、山证化工、国信证券、恒大人寿、 | | 国寿养老、健顺投资、长城财富保险、华宝基金、招商 | | 基金、淡水泉基金、开源证券、申万投资、中金公司 | | （资管）、大成基金、中欧基金、太平基金、长城财富 | | 资管、东海基金、瑞信致远基金、玄卜投资、信银理财、 | | 红杉资本、 Brilliance 才华资本、华夏久盈基金、新华基 | | 金、中国人寿资产、华泰资产、泰康资产、兴证全球基 | | 金、循远资产、朱雀基金、北京和聚私募基金、中国人 | | 寿养老保险、中国人寿资产、海南君阳私募基金、中海 | | 基金、交银理财、中科 ...

中国北京建国门外大街 1 号国贸写字楼 2 座 12-14 层 100004 12-14th Floor, China World Office 2, No. 1 Jianguomenwai Avenue, Beijing 100004, China 电话 Tel: +86 10 6563 7181 传真 Fax: +86 10 6569 3838 电邮 Email: beijing@tongshang.com 网址 Web: www.tongshang.com 北京市通商律师事务所 关于昊华化工科技集团股份有限公司2019年限制性股票 激励计划回购注销部分限制性股票实施情况 3.公司及相关公司、相关人员向本所及本所律师作出的书面陈述、说明、确认 和承诺均为真实、准确、全面和完整的，不存在任何虚假、重大遗漏、误导； 4.公司向本所及本所律师提供的文件资料，均与公司自该等文件资料的初始提 供者处获得的文件资料一致，未曾对该等文件资料进行任何形式上和实质上的更改、 删减、遗漏和隐瞒，且已按本所及本所律师合理的要求向本所及本所律师提供或披 露了与该等文件资料有关的其他辅助文件资料或信息，以避免本所及本所律师因该 等 ...

证券代码：600378 证券简称：昊华科技 公告编号：临 2024-073 昊华化工科技集团股份有限公司 股权激励限制性股票回购注销实施公告 年 5 月 16 日在上海证券交易所网站（www.sse.com.cn）及指定披露媒体刊登的 《昊华化工科技集团股份有限公司 2019 年年度股东大会决议公告》（公告编号： 临 2020-029）。 2024 年 8 月 29 日，公司第八届董事会第十九次会议及第八届监事会第十六 次会议审议通过了《关于审议调整公司 2019 年限制性股票激励计划回购价格的 议案》《关于审议回购注销公司 2019 年限制性股票激励计划部分限制性股票的 议案》，同意回购注销 233 名激励对象已获授但尚未解除限售的限制性股票合计 164,681 股，具体内容详见公司于 2024 年 8 月 31 日在上海证券交易所网站 （www.sse.com.cn）及指定披露媒体刊登的《昊华化工科技集团股份有限公司关 于调整公司 2019 年限制性股票激励计划回购价格的公告》（公告编号：临 2024-061）《昊华化工科技集团股份有限公司关于回购注销 2019 年限制性股票 激励计划部分限制性股票的公告 ...

Investment Rating - The report assigns a "Buy-B" rating for the company, indicating a positive outlook for its stock performance in the coming months [1][3]. Core Views - The fluorochemical cycle is at a bottoming phase, and the acquisition of Zhonghua Lantian enhances the company's fluorine industry layout [1]. - The company is expected to improve its core competitiveness and industry influence through independent innovation in key technologies [3]. Financial Performance - In the first half of 2024, the company achieved a revenue of 3.459 billion yuan, a year-on-year decrease of 19.63% [4]. - The net profit attributable to shareholders was 370 million yuan, down 26.32% year-on-year [4]. - The gross margin for the first half was 27.45%, an increase of 2.88 percentage points year-on-year, while the net margin was 10.71%, a decrease of 0.97 percentage points year-on-year [2][4]. Market Data - As of October 8, 2024, the closing price was 32.67 yuan, with a market capitalization of 36.223 billion yuan [3]. - The company has a circulating A-share market value of 29.751 billion yuan and a total share capital of 1.109 billion shares [3]. Future Earnings Estimates - The expected earnings per share (EPS) for 2024, 2025, and 2026 are projected to be 0.97 yuan, 1.48 yuan, and 1.88 yuan, respectively [3]. - The corresponding price-to-earnings (P/E) ratios for these years are estimated at 33.8, 22.1, and 17.4 [3]. Strategic Developments - The company completed the acquisition of Zhonghua Lantian, which is now a wholly-owned subsidiary, and plans to invest up to 4.5 billion yuan in various fluorochemical projects [3]. - The company aims to enhance its fluorochemical segment and improve synergy effects through these investments [3].

证券代码：600378 证券简称：昊华科技 公告编号：临 2024-072 昊华化工科技集团股份有限公司 关于 2024 年半年度业绩说明会召开情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对 其内容的真实性、准确性和完整性承担法律责任。 一、本次说明会召开情况 昊华化工科技集团股份有限公司（以下简称"公司"） 2024 年半年度业绩说 明会于 2024 年 9 月 27 日（星期五）下午 15:00-16:00，通过上海证券交易所上证 路演中心以网络互动形式召开。公司副董事长、总经理王军先生，独立董事李姝 女士，副总经理刘政良先生，财务总监、首席合规官、总法律顾问何捷先生及董 事会秘书苏静祎女士参加了说明会，并在信息披露允许的范围内就投资者关注的 事项与投资者进行了交流与沟通。 公司已于 2024 年 8 月 31 日在上海证券交易所网站（www.sse.com.cn）及《中 国证券报》《上海证券报》披露了《昊华科技关于召开 2024 年半年度业绩说明会 的公告》（公告编号：临 2024－066）。 二、投资者提出的主要问题及公司回复情况 问题一：定增事项，更 ...

2024 年第三次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 证券代码：600378 证券简称：昊华科技 公告编号：临 2024-071 昊华化工科技集团股份有限公司 一、 会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 90 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 990,654,579 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 89.3490 | (四) 表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东大会由公司董事会召集，副董事长王军先生主持，采用现场投票和 (一) 股东大会召开的时间：2024 年 9 月 20 日 (二) 股东大会召开的地点：北京市朝阳区小营路 19 号财富嘉园 A 座昊华大 厦 19 层会议室 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： 网络投票相结合的表决方式进 ...